Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 133

1.

Informed Family Member Involvement to Improve the Quality of Dementia Care in Nursing Homes.

Tjia J, Lemay CA, Bonner A, Compher C, Paice K, Field T, Mazor K, Hunnicutt JN, Lapane KL, Gurwitz J.

J Am Geriatr Soc. 2017 Jan;65(1):59-65. doi: 10.1111/jgs.14299. Epub 2016 Aug 22.

2.

Knowledge of and perceived need for evidence-based education about antipsychotic medications among nursing home leadership and staff.

Lemay CA, Mazor KM, Field TS, Donovan J, Kanaan A, Briesacher BA, Foy S, Harrold LR, Gurwitz JH, Tjia J.

J Am Med Dir Assoc. 2013 Dec;14(12):895-900. doi: 10.1016/j.jamda.2013.08.009. Epub 2013 Sep 24.

PMID:
24074962
3.

Rationales that providers and family members cited for the use of antipsychotic medications in nursing home residents with dementia.

Bonner AF, Field TS, Lemay CA, Mazor KM, Andersen DA, Compher CJ, Tjia J, Gurwitz JH.

J Am Geriatr Soc. 2015 Feb;63(2):302-8. doi: 10.1111/jgs.13230. Epub 2015 Jan 30.

PMID:
25643635
4.

Influences on Decision-Making Regarding Antipsychotic Prescribing in Nursing Home Residents With Dementia: A Systematic Review and Synthesis of Qualitative Evidence.

Walsh KA, Dennehy R, Sinnott C, Browne J, Byrne S, McSharry J, Coughlan E, Timmons S.

J Am Med Dir Assoc. 2017 Oct 1;18(10):897.e1-897.e12. doi: 10.1016/j.jamda.2017.06.032. Epub 2017 Aug 12. Review.

PMID:
28807433
5.

Reasons to prescribe antipsychotics for the behavioral symptoms of dementia: a survey in Dutch nursing homes among physicians, nurses, and family caregivers.

Cornegé-Blokland E, Kleijer BC, Hertogh CM, van Marum RJ.

J Am Med Dir Assoc. 2012 Jan;13(1):80.e1-6. doi: 10.1016/j.jamda.2010.10.004. Epub 2010 Dec 15.

PMID:
21450216
6.

Assessing approaches and barriers to reduce antipsychotic drug use in Florida nursing homes.

Ellis ML, Molinari V, Dobbs D, Smith K, Hyer K.

Aging Ment Health. 2015;19(6):507-16. doi: 10.1080/13607863.2014.952710. Epub 2014 Aug 28. Erratum in: Aging Ment Health. 2015;19(6):i.

PMID:
25166458
7.

Use of antipsychotics among elderly nursing home residents with dementia in the US: an analysis of National Survey Data.

Kamble P, Chen H, Sherer JT, Aparasu RR.

Drugs Aging. 2009;26(6):483-92. doi: 10.2165/00002512-200926060-00005.

PMID:
19591523
8.

The OBRA-87 nursing home regulations and implementation of the Resident Assessment Instrument: effects on process quality.

Hawes C, Mor V, Phillips CD, Fries BE, Morris JN, Steele-Friedlob E, Greene AM, Nennstiel M.

J Am Geriatr Soc. 1997 Aug;45(8):977-85.

PMID:
9256852
9.

Effectiveness of interventions to improve family-staff relationships in the care of people with dementia in residential aged care: a systematic review protocol.

Nguyen M, Pachana NA, Beattie E, Fielding E, Ramis MA.

JBI Database System Rev Implement Rep. 2015 Nov;13(11):52-63. doi: 10.11124/jbisrir-2015-2415. Review.

PMID:
26657464
10.

Off-label use of second-generation antipsychotic agents among elderly nursing home residents.

Kamble P, Sherer J, Chen H, Aparasu R.

Psychiatr Serv. 2010 Feb;61(2):130-6. doi: 10.1176/ps.2010.61.2.130.

PMID:
20123817
11.

Improving Nursing Home Compliance via Revised Antipsychotic Use Survey Tool.

Bach LL, Lazzaretto DL, Young CF, Lofholm PW.

Consult Pharm. 2017 Apr 1;32(4):228-238. doi: 10.4140/TCP.n.2017.228.

PMID:
28376988
12.

CMS Strategies To Reduce Antipsychotic Drug Use In Nursing Home Patients With Dementia Show Some Progress.

Lucas JA, Bowblis JR.

Health Aff (Millwood). 2017 Jul 1;36(7):1299-1308. doi: 10.1377/hlthaff.2016.1439.

PMID:
28679818
13.

Assessment of antipsychotic prescribing in Belgian nursing homes.

Azermai M, Elseviers M, Petrovic M, van Bortel L, Stichele RV.

Int Psychogeriatr. 2011 Oct;23(8):1240-8. doi: 10.1017/S104161021100024X. Epub 2011 Mar 22.

PMID:
21418723
14.

Error occurred: cannot get document summary

PMID:
30241987

15.

Antipsychotic drug use since the FDA black box warning: survey of nursing home policies.

Lester P, Kohen I, Stefanacci RG, Feuerman M.

J Am Med Dir Assoc. 2011 Oct;12(8):573-577. doi: 10.1016/j.jamda.2010.04.005. Epub 2010 Oct 2.

PMID:
21450177
16.

Predicting Off-Label Antipsychotic Medication Use in a Randomly Selected Nursing Home Sample Based on Resident and Facility Characteristics.

Mansbach WE, Mace RA, Clark KM, Firth IM, Breeden JK.

Res Gerontol Nurs. 2016 Nov 1;9(6):257-266. doi: 10.3928/19404921-20160920-03. Epub 2016 Sep 27.

PMID:
27665755
17.

Fidelity to a behavioral intervention to improve goals of care decisions for nursing home residents with advanced dementia.

Hanson LC, Song MK, Zimmerman S, Gilliam R, Rosemond C, Chisholm L, Lin FC.

Clin Trials. 2016 Dec;13(6):599-604. Epub 2016 Jun 7.

18.

Evaluation of neuroleptic drug use by nursing home elderly under proposed Medicare and Medicaid regulations.

Garrard J, Makris L, Dunham T, Heston LL, Cooper S, Ratner ER, Zelterman D, Kane RL.

JAMA. 1991 Jan 23-30;265(4):463-7.

PMID:
1670645
19.

Interventions to reduce inappropriate prescribing of antipsychotic medications in people with dementia resident in care homes: a systematic review.

Thompson Coon J, Abbott R, Rogers M, Whear R, Pearson S, Lang I, Cartmell N, Stein K.

J Am Med Dir Assoc. 2014 Oct;15(10):706-18. doi: 10.1016/j.jamda.2014.06.012. Epub 2014 Aug 8. Review.

20.

Behavioural and psychological symptoms of dementia and their management in care homes within the East of England: a postal survey.

Backhouse T, Killett A, Penhale B, Burns D, Gray R.

Aging Ment Health. 2014 Mar;18(2):187-93. doi: 10.1080/13607863.2013.819834. Epub 2013 Jul 26.

PMID:
23886404

Supplemental Content

Support Center